Ohio Public Employees Retirement System (OPERS)’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $536K | Sell |
2,685
-5,600
| -68% | -$1.11M | ﹤0.01% | 1466 |
|
|
2025
Q4 | $1.57M | Hold |
8,285
| – | – | ﹤0.01% | 1193 |
|
|
2025
Q3 | $1.47M | Hold |
8,285
| – | – | ﹤0.01% | 1232 |
|
|
2025
Q2 | $942K | Hold |
8,285
| – | – | ﹤0.01% | 1357 |
|
|
2025
Q1 | $871K | Buy |
8,285
+8,130
| +5,245% | +$919K | ﹤0.01% | 1348 |
|
|
2024
Q4 | $16.6K | Buy |
155
+36
| +30% | +$4.07K | ﹤0.01% | 2241 |
|
|
2024
Q3 | $11.9K | Buy |
119
+35
| +42% | +$3.52K | ﹤0.01% | 2124 |
|
|
2024
Q2 | $7.08K | Buy |
84
+41
| +95% | +$3.26K | ﹤0.01% | 1953 |
|
|
2024
Q1 | $3.14K | Buy |
+43
| New | +$3.17K | ﹤0.01% | 1947 |
|
|
2023
Q1 | – | Sell |
-161
| Closed | -$11K | – | 2009 |
|
|
2022
Q4 | $11K | Sell |
161
-576
| -78% | -$37.5K | ﹤0.01% | 1912 |
|
|
2022
Q3 | $40K | Buy |
737
+46
| +7% | +$2.7K | ﹤0.01% | 1905 |
|
|
2022
Q2 | $38K | Buy |
691
+72
| +12% | +$4.09K | ﹤0.01% | 1889 |
|
|
2022
Q1 | $43K | Buy |
619
+100
| +19% | +$7.25K | ﹤0.01% | 1903 |
|
|
2021
Q4 | $50K | Buy |
519
+133
| +34% | +$12.3K | ﹤0.01% | 1904 |
|
|
2021
Q3 | $34K | Buy |
386
+165
| +75% | +$12.8K | ﹤0.01% | 1943 |
|
|
2021
Q2 | $18K | Buy |
221
+133
| +151% | +$11.1K | ﹤0.01% | 1964 |
|
|
2021
Q1 | $8K | Buy |
+88
| New | +$8.32K | ﹤0.01% | 1962 |
|
|
2019
Q4 | – | Sell |
-25,217
| Closed | -$1.57M | – | 1911 |
|
|
2019
Q3 | $1.57M | Sell |
25,217
-15,860
| -39% | -$996K | 0.01% | 1041 |
|
|
2019
Q2 | $2.92M | Sell |
41,077
-46,471
| -53% | -$3.42M | 0.02% | 806 |
|
|
2019
Q1 | $6.87M | Sell |
87,548
-4,947
| -5% | -$375K | 0.04% | 443 |
|
|
2018
Q4 | $7.83M | Buy |
92,495
+10,362
| +13% | +$1.1M | 0.05% | 359 |
|
|
2018
Q3 | $14.1M | Sell |
82,133
-25,201
| -23% | -$3.8M | 0.07% | 266 |
|
|
2018
Q2 | $13.9M | Buy |
107,334
+11,802
| +12% | +$1.32M | 0.07% | 265 |
|
|
2018
Q1 | $9.84M | Sell |
95,532
-5,290
| -5% | -$523K | 0.05% | 359 |
|
|
2017
Q4 | $8.61M | Buy |
100,822
+33,429
| +50% | +$2.9M | 0.04% | 421 |
|
|
2017
Q3 | $5.72M | Buy |
67,393
+22,830
| +51% | +$1.81M | 0.03% | 566 |
|
|
2017
Q2 | $3.38M | Sell |
44,563
-3,410
| -7% | -$239K | 0.02% | 744 |
|
|
2017
Q1 | $3.17M | Sell |
47,973
-31,584
| -40% | -$2.08M | 0.02% | 743 |
|
|
2016
Q4 | $5.13M | Sell |
79,557
-1,475
| -2% | -$93.1K | 0.03% | 587 |
|
|
2016
Q3 | $5.16M | Hold |
81,032
| – | – | 0.03% | 536 |
|
|
2016
Q2 | $6.03M | Sell |
81,032
-15,783
| -16% | -$1.17M | 0.04% | 438 |
|
|
2016
Q1 | $6.47M | Sell |
96,815
-1,439
| -1% | -$87.5K | 0.04% | 403 |
|
|
2015
Q4 | $6.64M | Buy |
98,254
+952
| +1% | +$58.8K | 0.04% | 422 |
|
|
2015
Q3 | $5.2M | Buy |
97,302
+12,664
| +15% | +$768K | 0.03% | 491 |
|
|
2015
Q2 | $5.33M | Sell |
84,638
-31,259
| -27% | -$1.71M | 0.03% | 533 |
|
|
2015
Q1 | $5.58M | Sell |
115,897
-22,121
| -16% | -$848K | 0.03% | 492 |
|
|
2014
Q4 | $4.58M | Hold |
138,018
| – | – | 0.03% | 584 |
|
|
2014
Q3 | $4.05M | Hold |
138,018
| – | – | 0.02% | 614 |
|
|
2014
Q2 | $5.36M | Sell |
138,018
-12,504
| -8% | -$507K | 0.03% | 542 |
|
|
2014
Q1 | $6.32M | Sell |
150,522
-60,914
| -29% | -$2.54M | 0.04% | 461 |
|
|
2013
Q4 | $6.94M | Buy |
211,436
+32,060
| +18% | +$1.04M | 0.04% | 473 |
|
|
2013
Q3 | $4.84M | Buy |
+179,376
| New | +$5.05M | 0.03% | 607 |
|
Other funds holding LGND
VPM
VCM
NAMI
CC
Ohio Public Employees Retirement System (OPERS)'s LGND Position: Q1 2026 in Review
Ohio Public Employees Retirement System (OPERS) reduced its Ligand Pharmaceuticals (LGND) stake by 68% in Q1 2026, selling an estimated $1.11M and leaving 2,685 shares worth $536K. The position accounts for ﹤0.01% of the portfolio, ranked #1466.
Ohio Public Employees Retirement System (OPERS) first reported a position in LGND in Q3 2013 and has held it in 42 quarters since. The position peaked at $14.1M in Q3 2018. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.
- Ohio Public Employees Retirement System (OPERS) held 2,685 shares of Ligand Pharmaceuticals worth $536K as of Q1 2026.
- Ohio Public Employees Retirement System (OPERS) sold 5,600 Ligand Pharmaceuticals shares in Q1 2026, an estimated $1.11M.
- Ligand Pharmaceuticals made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q1 2026, its #1466 holding.
- Ohio Public Employees Retirement System (OPERS) first reported a position in Ligand Pharmaceuticals in Q3 2013 and has held it in 42 quarters since.
- Ohio Public Employees Retirement System (OPERS)'s Ligand Pharmaceuticals position peaked at $14.1M in Q3 2018.
- 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.
Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2026, filed 14 May 2026.